Skandinaviska Enskilda Banken (SEB)’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Hold |
3,978
| – | – | 0.01% | 633 |
|
|
2025
Q1 | $1.32M | Sell |
3,978
-3,820
| -49% | -$1.27M | 0.01% | 616 |
|
|
2024
Q4 | $2.43M | Sell |
7,798
-1,157
| -13% | -$361K | 0.01% | 539 |
|
|
2024
Q3 | $1.9M | Sell |
8,955
-26,157
| -74% | -$5.55M | 0.01% | 597 |
|
|
2024
Q2 | $9.81M | Hold |
35,112
| – | – | 0.05% | 259 |
|
|
2024
Q1 | $9.38M | Buy |
35,112
+29,840
| +566% | +$7.97M | 0.05% | 282 |
|
|
2023
Q4 | $1.22M | Hold |
5,272
| – | – | 0.01% | 668 |
|
|
2023
Q3 | $770K | Hold |
5,272
| – | – | 0.01% | 716 |
|
|
2023
Q2 | $1.22M | Buy |
+5,272
| New | +$1.22M | 0.01% | 668 |
|
|
2021
Q4 | – | Sell |
-17,800
| Closed | -$1.42M | – | 1044 |
|
|
2021
Q3 | $1.42M | Buy |
+17,800
| New | +$1.42M | 0.01% | 729 |
|